KRISTIN KEEBLER: Open Payments
NPI 1649500091 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 36 payments from 12 companies in 2025. Trend: 2023 $172 · 2024 $115 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $146 |
| Alkermes, Inc. | 3 | $56 |
| Tris Pharma Inc | 2 | $47 |
| Corium, LLC | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, Dyanavel XR, Azstarys, Auvelity, JARDIANCE, REXULTI.
Industry payments across NE — which companies pay providers there.
